Funded Tech Companies

CureVac

CureVac is a leading biopharmaceutical tech venture, based in Tübingen. Financial backing came from private investors, Coppel Capital and Sigma Group.

Company Overview

Contact Information

Company Background Information

Overview

CureVac (Nasdaq: CVAC) is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/13/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Menichella

        

Chief Financial Officer

Pierre Kemula

        

Chief Operating Officer

Franz-Werner Haas

        

Chief Scientific Officer

Mariola Fotin-Mleczek

        

Founder

Ingmar Hoerr

        

VP - Product Management

Florian Mülbe

        

Company Investors

• Coppel Capital
• Sigma Group
• Baillie Gifford
• Chartwave Limited
• Bill & Melinda Gates Foundation
• Elma Investments

Browse more funded tech companies:

Cureskin | Curevo Vaccine

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary